Author:
Jordan Colson, MD, FCAP, FASCP
Department of Pathology and Laboratory Medicine
University of Miami
Miami, Florida
Primary Audience:
Phlebotomists, Laboratory Technologists, Laboratory Directors
Secondary Audience:
Author:
Jordan Colson, MD, FCAP, FASCP
Department of Pathology and Laboratory Medicine
University of Miami
Miami, Florida
Primary Audience:
Phlebotomists, Laboratory Technologists, Laboratory Directors
Secondary Audience:
Pathologists, Clinical Scientists (Includes all sub-specialty areas), Students, Pathologist Assistants, Residents, and Students
Upon completion of this activity, you will be able to:
· recognize the clinical and epidemiologic implications of phenotypic-genotypic susceptibility testing discrepancies;
· identify select emerging methods for rapid phenotypic susceptibility testing;
· discuss the advantages and disadvantages of rapid phenotypic susceptibility testing; and
· describe the importance of active antimicrobial stewardship involvement in leveraging rapid phenotypic susceptibility testing for clinical benefit.